Recognition that mutant p53 permits P1 PLAC1 transcription in HGSOC tumors and that increased PLAC1 expression in these cancers leads to poor patient outcomes suggested that altering P1 PLAC1 transcription can be accomplished by targeting p53 itself. The gene discussed is TP53; the disease is cancer.